Lyme Disease: A Must-Read Issue

Think you have read everything about Lyme disease? Think again. In this issue, Dr. James Schaller’s “2013 Lyme Disease Checklist” challenges what you think that your patient is suffering from. How about these signs of Lyme disease: Low vitamin D level. Low DHEA. Low free T3 level. Low WBC count.Skin lesions with purple coloration. Light-headedness upon standing. Poor short-term memory. Sleeping in excess of nine hours. Insomnia. Buzzing and ringing in ears. Bladder dysfunction. Heart valve problems. Chest pains. Air hunger. Multiple joint defects. Exposure to ticks and history of tick bite in past. Take Schaller’s Lyme disease quiz and find out if you need to do diagnostic testing.

Nancy Faass’s interview of Eric Gordon, MD, and Wayne Anderson, ND, emphatically tells us to not use western blot testing from the conventional labs. The reagents are weak and generally read normal in patients with chronic Lyme disease. The testing provided by IGeneX have “reagents more sensitive to the pathogen,” providing a much better test. Best yet is the development of an accurate culture test for diagnosing Borrelia. Gordon thinks that the culture method provides convincing evidence that Lyme disease is present.

Once you have confirmed the Lyme disease diagnosis, oral and IV antibiotics may be administered. But Gordon and Anderson caution strongly against using antibiotics initially in chronic Lyme disease. Patients who have acute Lyme disease should be treated with oral antibiotics. For chronic patients, herbal therapies should be employed first to start a process of bolstering the immune system and improving liver and kidney functioning. Only after the patient’s systems are improved with herbal therapies should antibiotics be considered. Gordon and Anderson will use both oral and IV antibiotics but they prefer to pulse their treatment, several days on, and several days off, rather than maintaining antibiotics continuously.

And our interview with Chinese medicine specialists Cynthia Quattro, DAOM, and Bob Quinn, DAOM, suggest a “gentle medicine” approach to Lyme disease. The articles on Lyme disease are all a must-read in this issue.

Jonathan Collin, MD

Authors

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

The GMO-to-Cancer Pathway

By Michelle Perro, MD – Early-onset colorectal cancer, generally defined as colorectal cancer diagnosed before age 50, has been rising for decades. The phenomenon is particularly disturbing because many cases occur in people without an obvious hereditary cancer syndrome.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This